RE:RE:RE:15$ US Target reiterated today as wellI'm with Actuarial on this one. One-year survival for PDAC under all existing treatments is around 28%. The ASCO abstract (written before all results were in) stated that disease control was achieved in 33% of patients. Not sure how long their period of observation was in this study, but 33% is a "modest" improvement over 28%.
I'm not bashing - again, I'm very long on ONC. But they're at the stage where they're trying to find where it works and where it doesn't. Sometimes it'll show dramatic improvements over existing treatments, sometimes it won't do better than existing treatments, and sometimes you'll only see modest improvements.